Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Study Of Axitinib In Combination With Cisplatin And Capecitabine In Patients With Advanced Gastric Cancer

NCT00842244 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00842244
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00842244 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Study Of Axitinib In Combination With Cisplatin And Capecitabine In Patients With Advanced Gastric Cancer
Lead sponsor
Pfizer
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2009
Completion date
October 31, 2012
Enrollment
22 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

advanced gastric cancer, stomach neoplasms